INmune Bio, Inc.
INMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42,082 | -$30,008 | -$27,299 | -$30,340 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,605 | $7,368 | $7,149 | $4,796 |
| Change in WC | $1,037 | $10,436 | -$2,864 | -$3,086 |
| Other Non-Cash | $79 | $224 | $328 | $126 |
| Operating Cash Flow | -$33,361 | -$11,980 | -$22,686 | -$28,504 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$15,000 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$15,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10,000 | -$5,000 | $0 | $14,951 |
| Stock Issued | $27,789 | $775 | $699 | $80,253 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $422 | $0 | $30 | $1,153 |
| Financing Cash Flow | $18,211 | -$4,225 | $729 | $96,357 |
| Forex Effect | $224 | -$100 | -$700 | -$10 |
| Net Chg. in Cash | -$14,926 | -$16,305 | -$22,657 | $52,843 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,848 | $52,153 | $74,810 | $21,967 |
| End Cash | $20,922 | $35,848 | $52,153 | $74,810 |
| Free Cash Flow | -$33,361 | -$11,980 | -$22,686 | -$43,504 |